Key result
Hyperinsulinemia is linked to ~31% higher odds of arterial stiffness versus lower insulin levels.
Why the study?
The relationship between hyperinsulinemia and cardiovascular injury in real-world populations remains incompletely understood.
Does hyperinsulinemia increase the risk of arterial stiffness and subclinical myocardial injury in adults?
Cohort (n=30,343)
No
Does hyperinsulinemia increase the risk of arterial stiffness and subclinical myocardial injury in adults?
Odds Ratio: 1.31 (95% CI 1.22–1.4)
p-value: p=<0.001
Hyperinsulinemia is independently associated with early arterial stiffening but not subclinical myocardial injury, highlighting its potential as an early metabolic indicator of vascular remodeling.
Hyperinsulinemia may flag early vascular risk on routine labs; leaves open causal effects on stiffness progression or myocardial injury.
Hyperinsulinemia is an early metabolic abnormality commonly associated with insulin resistance, but its relationship with cardiovascular injury in real-world populations remains incompletely understood. We examined whether fasting insulin is related to arterial stiffening and early myocardial biomarker abnormalities in a large health-examination population. This real-world retrospective analysis enrolled 30,343 adults who received routine health examinations from January 2017 to November 2021. For individuals with multiple visits, the earliest examination was used as the baseline record. Fasting insulin was evaluated in quartile categories, a log-transformed continuous exposure, and a hyperinsulinemia indicator based on the cohort-specific 75th percentile. The binary arterial-stiffness endpoint was defined using a mean baPWV (brachial-ankle pulse wave velocity) threshold of 1400 cm/s or higher. Myocardial injury was evaluated by cardiac troponin I or T. Logistic regression models were fitted to quantify the relationships of fasting insulin and HOMA-IR (homeostatic model assessment of insulin resistance) with baPWV-related outcomes and myocardial injury markers. Dose-response patterns were explored using restricted cubic spline modeling. Subgroup analysis and sensitivity analysis were performed. Python (3.13.0) was used for statistical analysis. Higher insulin categories were accompanied by greater adiposity, blood pressure, glucose, HOMA-IR, triglycerides, baPWV, and arterial-stiffness. Hyperinsulinemia was correlated with arterial stiffness in the unadjusted model and adjusted model (OR, 1.31; 95% CI, 1.22–1.40, P < 0.001). Compared with the lowest insulin quartile, the highest quartile was associated with markedly increased odds of arterial stiffness (OR, 1.56; 95% CI, 1.41–1.74, P < 0.001). Spline curves indicated that fasting insulin and HOMA-IR were positively and non-linearly related to mean baPWV. In contrast, the association between hyperinsulinemia and composite myocardial injury was not statistically significant. In this large real-world health examination cohort, hyperinsulinemia was independently and consistently associated with increased arterial stiffness. However, its association with subclinical myocardial injury was weaker. These results support fasting insulin as a potential early metabolic indicator of vascular stiffening, whereas its relationship with myocardial injury requires further longitudinal investigation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Hyperinsulinemia (n=30,343). Hyperinsulinemia (fasting insulin ≥ 13.44 µIU/mL) vs. Fasting insulin < 13.44 µIU/mL was evaluated on Arterial stiffness (mean brachial-ankle pulse wave velocity ≥ 1400 cm/s) (OR 1.31, 95% CI 1.22-1.40, p=<0.001). Hyperinsulinemia was independently associated with a 31% increased odds of arterial stiffness (OR 1.31) compared to lower insulin levels in adults undergoing routine health examinations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: